1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Prescription Drug

Prescribed Medicines: Latest Market Trends and Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
30 votes

Global Prescription Drug Market

The worldwide market for prescription drugs (which represent a large amount of the global pharmaceutical industry) is forecast to reach almost $900 billion by 2015, according to research from Global Industry Analysts.

The prescription drug industry has been affected by the economic crisis in so far as health cutbacks have resulted in pricing pressure. Expiring patents and the subsequent availability of cheaper generic alternatives add further pressure. 

The market involves the sale of medication that necessitates a prescription from a medical professional. These medicines require a license and are regulated by law. They are separate from over-the-counter drugs, which do not require a prescription.

Market Challenges

Drug safety and efficacy being of utmost priority to the industry, careful attention to quality and testing along with safety standard surveillance are ongoing efforts required to meet the challenges of changing legislations and to avoid penalties from regulatory bodies as well as the threat of lawsuits from patients.

Another industry issue to manage is the long development time required for prescription drugs, for which clinical trials for new drugs can last up to 11 years. This is followed by regulatory body review and approval, which can add another two years before the drug can be launched on the market.

Safety is also a major concern in the marketing and sale of prescription drugs, with ongoing risk management equally having an impact. The US Federal Drug Administration (FDA)’s Risk Evaluation and Mitigation Strategy addresses the abuse of opioid drugs used for pain management and available by prescription. The FDA scheme promotes responsible prescriptions and use of opioid painkillers, including oxycodone, morphine and methadone. With the US government underlining the widespread abuse of prescription medication and associated deaths, the FDA’s strategy attempts to clamp down on the over-prescription of opioids to prevent the surplus from being sold through illegal routes. The FDA’s initiative includes a push for manufacturers of opioid painkillers to list information on the use, disposal and prescription of their products for medical professionals.

Leading Prescription Drugs

The top spot in the global prescription drugs market is held by oncology drugs for the treatment of cancer, followed by respiratory agents such as anti-inflammatory drugs, lung fluid replacement, decongestants, biologics and inhaled corticosteroids.

Lipid regulators are in third place but are likely to see a fall in growth as the segment’s top drug, Pfizer’s cholesterol treatment drug Lipitor, along with others in this category, is to see its patent expire paving the way for generic drugs.

US Top 20 Therapeutic Classes by Prescriptions - 2010 

Regional Market Share

The worldwide market is slowing in some regions but showing greater growth in others such as the Asia-Pacific area where growth to 2015 is forecast to be more dynamic than in current leading regions like the US, according to Global Industry Analysts.  

Today, the number one region for prescription drugs is the US. The US prescription drug market is characterized by fragmentation with no company outside of the top five enjoying revenue from sales of more than 5%.

Global market weight is likely to reposition itself to see greater growth in developing markets, with India and China leading the way with an expected 17% annual growth through 2014, Bloomberg reports.

Evolution of Chinese Antibiotics Export - 2006 to 2010

Read more »

You might be interested in these related markets:

Customer Support

Talk to Sam

+1 646 893 5945

1-10 of about 400 reports

Global Prescription Drug Markets - Forecast

  • January 2018
    12 pages
  • Health Services  

    Hospital  

  • World  

    Belgium  

View report >

Prescription Drug Industry in the US, Quarterly Update

  • June 2018
    16 pages
  • Prescription Dr...  

  • United States  

View report >

Prescription Drug Industry in the US and Canada - Forecast

  • January 2018
    13 pages
  • Prescription Dr...  

  • United States  

    Canada  

    North America  

View report >

Prescription Drug Statistics in the US

  • July 2018
    3 pages
  • United States  

    North America  

View report >

Prescription Drug Forecast Statistics in the US

  • June 2018
    3 pages
  • Prescription Dr...  

  • United States  

    North America  

View report >

The future of the Prescription Drug Industry in Australia

  • June 2018
    2 pages
  • Prescription Dr...  

  • Australia  

    Oceania  

View report >

The future of the Healthcare Industry in China

  • June 2018
    3 pages
  • Healthcare  

    Prescription Dr...  

  • China  

    Asia  

View report >

Global Prescription Drug Markets - Forecast

  • June 2018
    4 pages
  • Prescription Dr...  

  • World  

    United States  

View report >

The future of the Pharmaceutical Industry

  • June 2018
    47 pages
  • Pharmaceutical  

    Therapy  

    Antidiabetics  

  • World  

    United States  

    North America  

View report >

Prescription Drug Social Impact in the US

  • May 2018
    10 pages
  • Prescription Dr...  

  • United States  

View report >

Search in Prescription Drug Industry (About 400 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Discovery and Development, Generic Drug, OTC, Therapy

17 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 199 - $ 10995)

Anti-Obesity Prescription Drugs Market  - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

Anti-Obesity Prescription Drugs Industry: Forecasts to 2026

  • $ 5795
  • Industry report
  • November 2017
  • by Transparency Market Research

Global Anti-Obesity Prescription Drugs Market: OverviewThe global anti-obesity prescription drugs market is expected to witness a moderate growth attributed to growing prevalence of obesity globally. Moreover, ...

PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Dr ... $ 10995 December 2017

Prescription Drugs Markets in China $ 4000 April 2018

Company Profile: Bayer $ 3000 December 2017

Prescription Drugs Industry Forecasts - China Focus $ 1800 April 2018

Prescription Drugs Companies in China $ 1800 April 2018

Global Orphan Drugs Market- Industry Analysis & Outlook ... $ 800 June 2017

2017 U.S. Resale - Prescription drugs sold through Home ... $ 199 May 2017

Anti-Obesity Prescription Drugs Industry: Forecasts to ... $ 5795 November 2017

PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Dr ... $ 10995 December 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on